1. 2023
  2. The association between renal function decline and disease severity in sickle cell disease

    Gaartman, A. E., van Tuijn, C. F. J., Nur, E., Vogt, L. & Biemond, B. J., 23 Jan 2023, (E-pub ahead of print) In: American journal of hematology.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2022
  4. Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait

    SCORE consortium, Aug 2022, In: British journal of haematology. 198, 3, p. e42-e45

    Research output: Contribution to journalComment/Letter to the editorAcademic

  5. 2021
  6. Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors

    Gaartman, A. E., Sayedi, A. K., Gerritsma, J. J., de Back, T. R., van Tuijn, C. F., Tang, M. W., Heijboer, H., de Heer, K., Biemond, B. J. & Nur, E., 1 Sep 2021, In: British journal of haematology. 194, 5, p. 899-907 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2020
  8. Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial

    van Tuijn, C. F. J., Gaartman, A. E., Nur, E., Rijneveld, A. W. & Biemond, B. J., 1 Jul 2020, In: American journal of hematology. 95, 7, p. E160-E163

    Research output: Contribution to journalLetterAcademicpeer-review

ID: 4395726